| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |